| Danial Norjidi |
THE Pantai Jerudong Specialist Centre (PJSC) conducted a scientific symposium entitled ‘Novel Therapies in the Future of Cancer Care’ at the Lecture Theatre of the centre yesterday.
The event featured two guest speakers from Japan – Professor Dr Kanichi Seto and Professor Dr Hiroshi Terunuma.
Professor Dr Kanichi Seto is the Research and Development Director of the Boron Neutron Cancer Treatment Centre in Southern Tohoku General Hospital, while Professor Dr Hiroshi Terunuma is the Deputy Director of the Tokyo Clinic/Southern Tohoku Hospital Group as well as the Director of the Biotherapy Institute of Japan in Tokyo.
The proceedings saw opening remarks delivered by Executive Director of PJSC Dr Haji Mazrul Adimin bin Haji Awang Besar, who welcomed the attendees and the two guest speakers.
“We would like to thank both Professor Seto and Professor Terunuma for your time, and advice, to come and visit our centre here and help us out in the possibility of exploring and setting up the immunotherapy lab in Jerudong Park Medical Centre and also a new service of immunotherapy in PJSC.
“This also marks the first step of our affiliation and association,” he added. “They have accepted our invitation to be one of our centres’ visiting experts and most importantly, they have accepted our friendship.”
The symposium was divided into two sessions. Professor Seto spoke on the current role of Proton Therapy in head and neck cancer treatment, while Professor Terunuma presented the current role of Immunotherapy in cancer care.
In the second session, Professor Seto discussed the status of Boron Neutron Application for the future in head and neck cancer care while Professor Terunuma highlighted the application of Cell Therapy in cancer care, particularly NK Cell Therapy, Dendritic Cell Therapy, Apheresis and Tumour Lysate Antigen.
A question-and-answer session then ensued before the symposium concluded.